Fast 18F Labeling of a Near-Infrared Fluorophore Enables Positron Emission Tomography and Optical Imaging of Sentinel Lymph Nodes

R Ting, TA Aguilera, JL Crisp, DJ Hall… - Bioconjugate …, 2010 - ACS Publications
R Ting, TA Aguilera, JL Crisp, DJ Hall, WC Eckelman, DR Vera, RY Tsien
Bioconjugate chemistry, 2010ACS Publications
We combine a novel boronate trap for F− with a near-infrared fluorophore into a single
molecule. Attachment to targeting ligands enables localization by positron emission
tomography (PET) and near-infrared fluorescence (NIRF). Our first application of this generic
tag is to label Lymphoseek (tilmanocept), an agent designed for receptor-specific sentinel
lymph node (SLN) mapping. The new conjugate incorporates 18F− in a single, aqueous
step, targets mouse SLN rapidly (1 h) with reduced distal lymph node accumulation, permits …
We combine a novel boronate trap for F with a near-infrared fluorophore into a single molecule. Attachment to targeting ligands enables localization by positron emission tomography (PET) and near-infrared fluorescence (NIRF). Our first application of this generic tag is to label Lymphoseek (tilmanocept), an agent designed for receptor-specific sentinel lymph node (SLN) mapping. The new conjugate incorporates 18F in a single, aqueous step, targets mouse SLN rapidly (1 h) with reduced distal lymph node accumulation, permits PET or scintigraphic imaging of SLN, and enables NIRF-guided excision and histological verification even after 18F decay. This embodiment is superior to current SLN mapping agents such as nontargeted [99mTc]sulfur colloids and Isosulfan Blue, as well as the phase III targeted ligand [99mTc]SPECT Lymphoseek counterpart, species that are visible by SPECT or visible absorbance separately. Facile incorporation of 18F into a NIRF probe should promote many synergistic PET and NIRF combinations.
ACS Publications